Germany
Japan
United Kingdom
China
Rabbit Polyclonal Anti-SARS Spike Antibody
| Reactivities | Yeast |
| Immunogen | SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids at the amino-terminus of. The sARS Spike glycoprotein. |
Primary Antibodies
View as table DownloadRabbit Polyclonal Anti-SARS Spike Antibody
| Reactivities | Virus |
| Immunogen | SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids near the center of. The sARS Spike glycoprotein. |
Rabbit Polyclonal Anti-SARS Spike Antibody
| Reactivities | Virus |
| Immunogen | SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids near the center of. The sARS Spike glycoprotein. |
Rabbit Polyclonal Anti-SARS Spike Antibody
| Reactivities | Virus |
| Immunogen | SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids near the center of. The sARS Spike glycoprotein. |
Rabbit Polyclonal Anti-SARS Spike Antibody
| Reactivities | Virus |
| Immunogen | SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids at the carboxy terminus of the SARS Spike glycoprotein. |
Mouse anti Hepatitis B virus surface Ag Monoclonal Antibody
| Reactivities | Human |
Mouse anti HBsAg Monoclonal Antibody
| Reactivities | Human |
Mouse anti HBsAg Monoclonal Antibody
| Reactivities | Human |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
| Modifications | This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
| Modifications | This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#14)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#14)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#14)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#14)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#14)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#16)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#16)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#16)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#16)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#16)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#42)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#42)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#42)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#42)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#42)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#45)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#45)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#45)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#45)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Spike protein (RBD) (Clone Sb#45)
| Applications | ELISA, Inhib |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. |
SARS-CoV/SARS-CoV-2 Variant (Beta, Delta, Omicron (BA.5)) Spike Trimer Antibody [P1A7]
| Applications | ELISA |
| Reactivities | Virus |
| Conjugation | Unconjugated |
Active filters
Category
- Antibodies
Target Symbol
- S
Filter by
Reactivities
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)